IMN || News

One health system cut diabetes events, with set patient measures and cash for physicians

Posted on: 23/01/2014 - 19:30

An incentivized, system-based approach to improve care for patients with diabetes and other chronic diseases appeared to pay off after just 3 years by significantly cutting the incidence of adverse...

Field of Interest: Endocrinology

Type: News Item

Immunosuppressive therapy ups risk for skin cancers

Posted on: 23/01/2014 - 14:35

HOLLYWOOD, FLA. – Current and previous use of thiopurines, biologics, and combination therapies are all independent risk factors for skin cancer, according to expert analysis given at a conference on...

Field of Interest: Gastroentero...

Type: News Item

Two Alzheimer’s immunotherapy drugs flunk in four studies

Posted on: 22/01/2014 - 22:00

Two investigational Alzheimer’s immunotherapies failed to show any benefit in a series of phase III trials comprising more than 4,000 patients. Neither bapineuzumab, which targets soluble and...

Field of Interest: Geriatrics

Type: News Item

Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

Posted on: 22/01/2014 - 18:40

HOLLYWOOD, FLA. – The benefits of short-term trial immunosuppressive therapy outweigh the risks in inflammatory bowel disease, but certain patient populations require more vigilance than others, Dr....

Field of Interest: Gastroentero...

Type: News Item

MicroRNA screening might reveal pancreatic cancer

Posted on: 21/01/2014 - 22:20

Researchers have identified two novel panels of microRNAs that eventually might be used to screen patients for pancreatic cancer, distinguishing affected patients from healthy individuals and from...

Field of Interest: Endocrinology

Type: News Item

The price and cost of hepatitis C treatment

Posted on: 16/01/2014 - 19:55

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease affecting 180 million people globally. HCV infection, both silent and slow in its revelation, and devastating in its...

Field of Interest: Gastroentero...

Type: News Item

Dual-vaccine therapy prolonged survival in pancreatic cancer

Posted on: 16/01/2014 - 18:35

SAN FRANCISCO – Serial administration of two vaccines that stimulate the immune response to pancreatic cancer antigens prolonged survival of metastatic disease by about 2 months, according to Dr....

Field of Interest: Gastroentero...

Type: News Item

Daclatasvir-sofosbuvir combo scores in resistant hepatitis C

Posted on: 15/01/2014 - 22:00

A combined regimen of daclatasvir and sofosbuvir achieved sustained virologic response rates greater than 90% in an industry-sponsored trial involving patients with chronic HCV, according to study...

Field of Interest: Gastroentero...

Type: News Item

‘Obesity paradox’ refuted

Posted on: 15/01/2014 - 22:00

Mortality is not lower among adults with diabetes who were overweight or obese at diagnosis than among those who were of normal weight, as has been suggested by proponents of the "obesity...

Field of Interest: Endocrinology

Type: News Item

Expanded genetic testing better predicts panitumumab plus chemo response

Posted on: 15/01/2014 - 19:50

SAN FRANCISCO – Patients with metastatic colorectal cancer should be broadly tested for RAS mutations before being treated with panitumumab, according to new data from a <link...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters